Research groups
James Charlesworth
BM BCh BMedSc MSc PhD MRCPCH
Clinical Lecturer in Paediatric Infectious Disease and Immunology
I am a paediatric registrar within the Thames Valley deanery with a background in immunology research. I completed my masters in Immunology in 2010 and PhD in 2015, focusing on regulatory B cells in allergy and allergen immunotherapy. I subsequently studied graduate entry medicine and postgraduate training in paediatrics. I have maintained an interest in immunoregulation and treatments to target specific immune dysregulation.
I am currently undertaking a clinical fellowship with Professor Uhlig exploring gastrointestinal outcomes for patients with specific immune defects given molecularly targeted treatments, based on their diagnosis. These patients predominantly have inborn errors of immunity (IEI, previously 'primary immunodeficiency disorders' - PID) and often don't respond to classical treatments for IBD. Alongside this, we are working with the paediatric immunology department (Dr Smita Patel and Prof. Dominic Kelly) to explore approaches to advance early diagnostics in IEI.
Recent publications
Mind the (preterm) gap: inequality in the UK's current RSV immunisation approach will leave many preterm babies unprotected against RSV this winter.
Journal article
Charlesworth JEG., (2025), Arch Dis Child, 110, 662 - 664
Severe Parvovirus B19-Associated Myocarditis in Children in the Post-COVID-19 Era: A Multicenter Observational Cohort Study.
Journal article
Russell N. et al, (2025), Open Forum Infect Dis, 12
Vitamin D may influence disease course in PIMS-TS/MIS-C: An observational cohort study.
Journal article
Charlesworth JEG. et al, (2025), Pediatr Int, 67
Catalyzing change: Implementing standardised reporting in monogenic inflammatory bowel disease research.
Journal article
Yeh P-J. et al, (2024), J Pediatr Gastroenterol Nutr, 78, 759 - 762
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution.
Journal article
Ng MTH. et al, (2024), Nat Commun, 15
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution
Journal article
Ng MTH. et al, (2024), NATURE COMMUNICATIONS, 15
FCGR2A-131H/H is under-represented amongst patients with primary immunodeficiencies
Preprint
Flewitt EWD. et al, (2023)
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Journal article
Charlesworth JEG. and Kavirayani A., (2023), Eur J Haematol, 111, 458 - 476